ALLIANCE FOR AGING RESEARCH

-FY25 report language for the Food and Drug Administration -FY25 report language for the Medicare Program -FY25 report language for the Medicare Prescription Payment Plan

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -H.R.3008 - Drug Shortage Prevention Act of 2023 -On the creation of an executive branch Office of Caregiver Health -Rollout of 2024 Covid-19 vaccines -HR 2630, the Safe Step Act -H.R.8816 - American Medical Innovation and Investment Act of 2024 -Pharmacy benefit manager reform

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Beneficiary access to diabetes management devices -Vaccine access issues -White House Initiative on Womens Health Research

-FY24 report language for the Food and Drug Administration -FY25 report language for the Food and Drug Administration -FY25 report language for the Medicare Program -National Institute of Allergy and Infectious Diseases

-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform